SCHEMBL19626637

SCHEMBL19626637

CN1C(=O)c2c(ncn2CC(=O)Nc2ccc(-c3ccccc3)nc2)N(C)C1O

nearest known ligand 0.51

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ PORCN Q9H237 3/20 0.51
▸ WNT3A P56704 12/20 0.42
▸ PTPN1 P18031 2/20 0.40
▸ PTPN2 P17706 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19626366 0.87 PORCN (0.42) PORCNWNT3A
SCHEMBL23416909 0.85 PORCN (0.58) PORCNWNT3A
SCHEMBL19590943 0.82 GAA (0.45) —
SCHEMBL19997382 0.82 PORCN (0.40) PORCN
SCHEMBL20290287 0.82 POLB (0.51) —
SCHEMBL19997366 0.81 POLB (0.46) —
SCHEMBL19626687 0.81 SMN1; SMN2 (0.42) —
SCHEMBL20029975 0.81 MEN1 (0.48) —
SCHEMBL21935695 0.81 PORCN (0.46) PORCN
SCHEMBL22105261 0.80 PSEN1 (0.41) PORCN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10472360-B2 Purine diones as Wnt pathway modulators AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2019-11-12 — — US disclosed
US-20170334912-A1 Purine Diones As Wnt Pathway Modulators AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2017-11-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170334912-A1 Purine Diones As Wnt Pathway Modulators WNT1, WNT3A, CTNNB1 PORCN 3761/4885WNT3A 2/4885PTPN1 3647/4885
US-10472360-B2 Purine diones as Wnt pathway modulators WNT1, WNT3A, CTNNB1 PORCN 3761/4885WNT3A 2/4885PTPN1 3647/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback